Patent details

EP3514179 Title: ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

Basic Information

Publication number:
EP3514179
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP182113738
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
French Title of Invention:
MOLÉCULES D'ANTICORPS ANTI-PD-1 ET LEURS UTILISATIONS
German Title of Invention:
ANTIKÖRPERMOLEKÜLE GEGEN PD-1 UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
23/01/2015
Grant date:
02/11/2022
EP Publication Date:
24/07/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/11/2022
EP B1 Publication Date:
02/11/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/01/2023
Expiration date:
23/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2022
 
 

Name:
Dana-Farber Cancer Institute, Inc.
Address:
450 Brookline Avenue, Boston, MA 02115-5450, United States (US)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
President and Fellows of Harvard College
Address:
17 Quincy Street, Cambridge, MA 02138, United States (US)

Inventor

1

Name:
BLATTLER, Walter, A.
Address:
United States (US)

2

Name:
FREEMAN, Gordon, James
Address:
United States (US)

3

Name:
MATARAZA, Jennifer, Marie
Address:
United States (US)

4

Name:
FREY, Gerhard, Johann
Address:
United States (US)

5

Name:
SABATOS-PEYTON, Catherine, Anne
Address:
United States (US)

6

Name:
SHARPE, Arlene, Helen
Address:
United States (US)

7

Name:
CHANG, Hwai, Wen
Address:
United States (US)

Priority

1

Priority Number:
201461931512 P
Priority Date:
24/01/2014
Priority Country:
United States (US)

2

Priority Number:
201462059676 P
Priority Date:
03/10/2014
Priority Country:
United States (US)

3

Priority Number:
201462094834 P
Priority Date:
19/12/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; C07K 16/30; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202244
Publication date:
02/11/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages